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Introduction: The obstructive sleep apnea syndrome (OSAS) is a respiratory illness, 
characterized by recurrent episodes of apnea and hypopnea, leading to reduction 
or cessation of the airflow. Obesity is one of the major risk factors for the development 
of OSAS. To help in the diagnosis of this disease, easily applicable and low-cost 
questionnaries were developed, such as the Berlin Questionnaire (BQ). 
Objective: To evaluate the efficacy of the BQ for the screening of OSAS among 
candidates to bariatric surgery in a multidisciplinary preoperative program. 
Method: This is an observational, descriptive and cross-sectional study which 
evaluated obese individuals that were being prepared for bariatric surgery by 
means of the BQ. 
Results: BQ was able to detect that minimal variations in the body mass index, neck 
circumference and hip-to-waist ratio lead to changes in the risk to develop OSAS; 
the higher the values of these variables, the higher the risk for OSAS development. 
Conclusion: BQ was an efficient and reliable tool to demonstrate the high risk 
for OSAS development in individual with obesity.
Keywords: obesity, sleep apnea, obstructive sleep apnea, bariatric surgery, surveys 
and questionnaires.
introduction
Obstructive sleep apnea syndrome (OSAS) is a respira-
tory disorder characterized by recurrent episodes of ap-
nea and hypopnea, which results in the cessation or re-
duction of airflow and may be accompanied or not by a 
collapse of the upper airways. It occurs as a consequence 
of the physiological relaxation of muscles during sleep, 
for a period greater than or equal to ten seconds, thus 
leading to a decrease in blood oxygen saturation, i.e. hy-
poxemia and even hypercapnia, found in patients with 
severe OSAS and a high body mass index (BMI).1-5
The syndrome is identified based on polysomnography 
results. The technique aims at noninvasively investigating 
sleep disorders and entails simultaneously recording pa-
rameters such as heart and respiratory rates, respiratory 
flow and effort, pulse oximetry, the quantification of re-
spiratory events (both obstructive and central ones), snor-
ing, levels of brain electrical activity, eye movement and 
muscle activity. The test is performed during sleep and 
the parameters are then recorded by sensors attached to 
various parts of the patient’s body using self-adhesive 
tapes. After analyzing the data, OSAS is classified accord-
ing to the number of respiratory events and the apnea-
-hypopnea index (AHI): it is considered mild when 5 to 15 
events/hour are recorded; moderate is 15 to 30 events/hour; 
and severe is a mean of ≥ 30 events/hour.5-11 
Individuals may have distinct symptoms, namely 
excessive daytime sleepiness, depressive states, impaired 
memory and learning abilities, poor concentration and 
attention span, and cardiovascular diseases, which can 
culminate in sudden death. OSAS is a progressive chron-
ic disease that directly influences quality of life, given that 
sleep is a brain function that is essential to life and aids 
in relieving human stress.1,7,8,12-14
While obesity is one of the major risk factors for de-
veloping OSAS, it is the only one that is reversible. Ac-
cording to the World Health Organization (WHO), an 
individual is considered obese when he or she has an 
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abnormal or excessive energy reserve in the form of fat. 
Its incidence has been progressively increasing over the 
last years, having reached epidemic levels worldwide, es-
pecially in industrialized countries.1,2,5 In accordance with 
WHO guidelines, obesity is classified based on BMI, which 
is calculated by dividing body weight, in kilograms, by 
the height squared, in meters.4 Some authors, in turn, set 
a cut-off value of BMI > 30 as a risk factor for the develop-
ment of OSAS. Central obesity is established when the waist-
to-hip ratio measurement is greater than 102 cm in males 
and greater than 88 cm in females something also associ-
ated with a neck circumference measurement greater than 
40 cm. Neck and abdominal fat accumulation is one of the 
factors responsible for the syndrome in the obese.4,8,12,13 
In fact, 70% of all patients diagnosed with OSAS are 
obese. The incidence of OSAS among patients with class 
III obesity, i.e. BMI greater than 40, is 12 to 30 times great-
er than in the general population.8 The incidence of OSAS 
is 42-48% in obese males, and 8-38% in obese females.13,14
The actual cause of the syndrome remains unknown, 
but it is known to occur in any age group, becoming more 
evident among individuals aged 40-50 years. Males are 
8 to 10 times more affected than females, due to their 
hormonal profile, body fat distribution and differences 
in upper airway anatomy. Females usually have OSAS 
when they go through menopause, are obese and aged 
60 to 69 years.2,5,6,14
The incidence and prevalence of OSAS are not fully 
defined, for there are reports stating that 75% of the 
population will never be formally diagnosed, which makes 
treatment difficult and contributes to high morbidity 
and mortality rates associated with the disease.2,15,16 
Laboratory-based polysomnography is the gold stan-
dard for diagnosing the disease. Disadvantages include its 
high cost and the discomfort experienced by some indi-
viduals during the test; however, devices for home use have 
been studied that yield satisfactory results when diagnos-
ing OSAS.13,16 Other methods are intended to assist in 
diagnosing the disease, such as inexpensive questionnaires 
that can be easily administered, which is the case of the 
Berlin Questionnaire (BQ).17 
 The BQ emerged in 1996 in Berlin as a result of a 
conference on sleep respiratory disorders and primary 
health care. Created with the objective of tracking the risk 
of developing OSAS, it is now one of the most recognized 
instruments in this field. The questionnaire consists of 
three categories with questions scoring 1 to 2 points ac-
cording to the response given by the individual being as-
sessed. The first category in the BQ comprises five questions 
on snoring and witnessed apneas and is considered positive 
if the sum of the responses reaches 2 points, i.e. when the 
individual responds with a “yes” if they snore, if their snor-
ing is louder than their voice, if this happens almost every 
day or at least 3 to 4 times per week, if their snoring has 
ever disturbed other people and if breathing pauses have 
been witnessed at least 3 to 4 times per week; the second 
category has three questions on fatigue early in the morn-
ing and during the day, or on whether the individual has 
ever fallen asleep while driving. If they respond affirma-
tively to at least two of the questions in this category, it is 
already considered a positive result that yields 2 points. 
The third category, in turn, consists of only one question 
on systemic arterial hypertension and is considered positive 
if the answer is yes; still, this category can also be considered 
positive if the individual has a BMI greater than 30 kg/m2. 
The assessed individual is considered a high-risk patient 
when he or she has scored positively in two or more catego-
ries, while a low-risk patient is someone who scored posi-
tively in none or only one category.17
This study is aimed at assessing the BQ’s effectiveness 
in screening the prevalence of the risk of developing 
OSAS in individuals with obesity grades I, II, III partici-
pating in the multidisciplinary preoperative preparation 
program for bariatric surgery at HC/UNICAMP by cor-
relating their results with anthropometric measurements, 
age and gender.
Method
This cross-sectional, observational and descriptive study 
was carried out between February 2015 and February 2016, 
and involved patients with obesity grades I, II and III of 
both genders, adults over 18 years of age, who partici-
pated in the multidisciplinary preoperative preparation 
program for bariatric surgery at Hospital de Clínicas – 
Unicamp. Individuals with previous respiratory illnesses, 
smokers, those working in sectors with a high occupa-
tional risk for lung disease and members of vulnerable 
groups were excluded from the study.
Study participants were asked to answer the BQ and 
to fill out the data sheet with information on gender and 
age. Data on height, weight, BMI and anthropometric 
measurements, such as neck (NC) and waist (WC) circum-
ferences, and waist-hip ratio (WHR), were collected from 
each patient’s medical records. The study was approved by 
the Research Ethics Committee at Universidade Estadual 
de Campinas-Unicamp, opinion No. 1,488,299, with all of 
its participants having signed a voluntary informed consent 
form prior to being included in the study. Individuals were 
classified as being at a high or low risk of developing OSAS 
by summing up the scores for all three categories in the 
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QB, with the risk being considered high when they had 
scored positively in two or more categories, and low when 
they had scored positively in one or no category at all.
Statistical analysis
Frequency tables with the categorical variables accompa-
nied by absolute (n) and percentage (%) values were made 
for describing the profile of the sample. A series of descrip-
tive statistics for the variables was calculated and com-
prised mean, standard deviation, minimum value, maxi-
mum value and median. The Mann-Whitney test was used 
for comparing numerical variables. For the categorical 
variables, a Chi-squared test was used. A level of signifi-
cance of 5% was adopted in the study.
results
Of the 502 individuals who started out participating in 
the preoperative preparation program for bariatric surgery 
and filled in the BQ, 29 were excluded due to errors in 
filling in the questionnaire and divergences in their re-
sponses, thus totaling 473 obese individuals. Of these, 414 
(82%) were female and 88 (17%) were male; their age and 
anthropometric characteristics are described in Table 1.
TABLE 1 Age and anthropometric characteristics  
of individuals.
Variables Mean (SD) 
Age (years) 38±10 
Weight (kg) 126.13±29 






BMI: body mass index; NC: neck circumference; WHR: waist-hip ratio.
Results presented as mean and standard deviation.
The frequencies of questionnaire responses within each 
BQ category were analyzed, as seen in Table 2.
In category 1, 473 BQs were analyzed, of which only 
363 individuals answered question number 1 with a “yes,” 
indicative of their snoring. The remaining 110 individu-
als responded to the question with a “no” or a doubt and, 
with that, did not respond to any further questions in 
this category.
Category 2 in the BQ is related to daytime sleepiness 
and, among the 473 individuals who provided answers 
in this category, there was practically no difference in 
TABLE 2 Descriptive frequencies of responses in categories 
1, 2 and 3 presented as absolute and relative values.
Category 1 Freq %
1. Do you snore?
Yes 363 74.85
No 52 10.72
I don’t know 58 14.43
If you snore:
2. Your snoring is:
a. Slightly louder than your breathing. 193 53.42
b. As loud as when you speak 62 16.99
c. Louder than when you speak 22 6.03
d.  So loud it can be heard in the other rooms  
of the house
86 23.56
3. How often do you snore?
a. Almost every day 265 73.2
b. 3-4 times a week 54 14.92
c. 1-2 times a week 28 7.73
d. 1-2 times a month 6 1.66
e. Never or almost never 10 2.49
4. Has your snoring ever bothered other people?
a. Yes 257 70.8
b. No 54 14.88
c. I don’t know 52 14.43
5. Has anyone noticed that you stop breathing while you sleep?
a. Almost every day 82 22.53
b. 3-4 times a week 19 5.22
c. 1-2 times a week 32 8.79
d. 1-2 times a month 20 5.49





6.  How often do you feel tired or fatigued after a 
night’s sleep?
Freq %
a. Almost every day 222 47.38
b. 3-4 times a week 42 8.81
c. 1-2 times a week 74 15.51
d. 1-2 times a month 29 6.08
e. Never or almost never 106 22.22
7. During the day, do you feel tired, fatigued or unable to face it?
a. Almost every day 253 56.45
b. 3-4 times a week 53 10.37
c. 1-2 times a week 65 13.13
d. 1-2 times a month 43 8.06
e. Never or almost never 59 11.98
(continues)
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TABLE 3 Comparison of numerical variables with a high 
or a low risk of developing OSAS. 
Variables High risk (n=390) Low risk (n=93)
Mean SD Mean SD p-value
Age (years) 39.95 10.16 34.3 10 <0.0001
Weight (kg) 127.31 30 121.22 28.52 0.1219
Height (m) 1.64 0.09 1.64 0.09 0.1559
BMI 47.32 8.86 44.72 8.81 0.0111
NC 43.5 6.08 41.05 4.67 <0.0001
Waist 129.31 20.11 122.75 17.81 0.008
Hip 142.46 17.68 140.47 19.27 0.1845
WHR 0.91 0.11 0.88 0.11 0.0032
Male 71 85.54 12 14.46
Results presented in mean, median and standard deviation, p-value for the Mann-Whitney 
test, p<0.05. 
discussion
There is evidence in the literature that obesity is a risk 
factor for obstructive sleep apnea, given that overweight 
acts directly upon the pathophysiology of the narrow-
ing of the upper airways and involvement of the oropha-
ryngeal muscles.18 
The present study was conducted within a preopera-
tive program for bariatric surgery aimed at preparing 
individuals with obesity who are candidates for surgery, 
under the guidance of a multidisciplinary team, in order 
to provide measures that healthily lead to weight reduc-
tion. In this program, the number of obese women is 
greater than that of obese men, which can be explained 
by factors that are intrinsic to the female gender and the 
demand for health services. According to Gomes et al.,19 
this refers to the fact that caring is associated more with 
women, which is justified by the way females are taught 
to socialize from an early age.19 However, the present study 
showed no difference in the risk of developing OSAS 
between males and females (p-value=0.188). Some studies 
reported associations between OSAS and the male gender 
that were attributed to hormonal profile, anatomical, 
functional and craniofacial changes and structural dif-
ferences in the upper airways in men and women during 
sleep, with more favorable mechanics having been identi-
fied in women. This can occur due to the distribution of 
fat in males, which implies an accumulation of fat tissue 
in the upper part of their body, thus favoring a greater 
collapse of the upper airways in males.20-23 
After evaluating Category 1 in the BQ, we found that 
70% of the sample scored positively, which demonstrates 
that these individuals have snoring symptoms and witnessed 
apneas. Snoring and sleep apnea are both the progression 
of a single problem to OSAS. Nevertheless, it is known that, 
TABLE 2 (cont.) Descriptive frequencies of responses in 
categories 1, 2 and 3 presented as absolute and relative values.
Category 2
8. Have you ever dozed or fallen asleep while driving?
a. Yes 29 10.4
b. No 424 89
If your answer was yes
9. How often does this occur? 
a. Almost every day 10 24.95
b. 3-4 times a week 6 10.17
c. 1-2 times a week 6 10.17
d. 1-2 times a month 5 7.42





10. Do you have high blood pressure? Freq %
a. Yes 254 53.8
b. No 164 34.6




their scores, since both scored 50% for both the positive 
and negative categories (Table 2).
Still with reference to Category 2 in the BQ, question 
number 8, only 49 individuals responded with a “yes,” 
meaning that only these 49 individuals went on to respond 
to question number 9 (Table 2). 
Category 3 has a question on systemic arterial hyper-
tension and can also be considered a positive category 
when an individual has a BMI greater than 30 kg/m2, 
which thus characterizes obesity grade 1. Therefore, in 
our study, this category was 100% positive (Table 3).
A low or a high risk of OSAS was determined based on 
the responses in each item category. Of the 473 individuals 
participating in the study, 80.34% were found to be at a 
high risk versus 19.66% at a low risk of developing OSAS.
The variables gender, age and anthropometric measure-
ments associated with a high or a low risk of developing OSAS 
were studied and compared. The variables age, BMI, NC, WC 
and WHR were statistically different, as seen in Table 3.
When comparing high- and low-risk categorical vari-
ables for males (n=71) and females (n=309) in the develop-
ment of OSAS, we found no significant difference, as seen 
by the p-value (0.1889), even though females were the ma-
jority among all individuals participating in the study. 
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in the absence of this pathology, a force imbalance in the 
oropharyngeal muscles – as they relax in the phases of 
sleep – can favor a collapse of the upper airways.24,25
In obesity, it is not only muscles that cause respira-
tory obstruction, but also a layer of excess fat along the 
soft palate and the tonsillar region that involves practi-
cally all face and neck muscles, leading thus to a narrow-
ing of the throat (pharynx) and giving it a more rounded 
shape, with the thickness of the fat layer being directly 
related to the increase in BMI.24,25 
The gastroesophageal reflux disease present in many 
patients with obesity, albeit not found in our study, could 
also explain the snoring and apnea symptoms in these 
individuals. When there is a collapse of the upper airways, 
there occurs an increase in the negative intrathoracic pres-
sure during inspiration. This in turn compresses the stom-
ach and causes the gastric acid to be pushed into the 
esophagus, thereby causing an aspiration; this acid stimu-
lates the pH receptors located in the trachea, and the au-
tonomic nervous system responds with a prolongation of 
apnea duration, thus acting as a defense mechanism which 
prevents acid aspiration from being more extensive.26,27
Still with regard to Category 1, the question on the 
loudness of snoring shows that 53% of participants re-
garded their snoring as “slightly louder than their breath-
ing”: this factor is referred to as heavy breathing (snorting) 
or low-pitched snoring. According to Marcos,27 individuals 
who snort do not have OSAS. When snorting becomes as 
intense as to disturb other people, it is considered a path-
ological condition and thus deemed snoring.27
In our study, 23% of individuals reported that their 
snoring was “so loud that it could be heard in other rooms 
of (their) home,” whereas 70% reported that they were 
aware that their snoring had already disturbed other 
people. The severity of snoring can be established by epi-
sodes of apnea. In our study, 22% of participants answered 
“Almost every day of the week” when asked “Did anyone 
notice whether you stop breathing while you sleep?” Obese 
individuals rarely snort, and their snoring is often loud 
and followed by episodes of apnea and hypopnea occur-
ring with a higher frequency, which increases the risk of 
developing OSAS.6,7,27
When analyzing the responses to the questions in 
Category 2, 47% of respondents reported that they feel 
tired or fatigued after a night’s sleep, and 56% of them 
reported that during the day they feel tired, fatigued or 
unable to cope with their daytime activities.
In Category 2, we found that the quality of sleep di-
rectly affects daily life activities and the quality of life 
(QOL) of obese individuals, who already experience a 
limitation to their QOL due to excess weight and associ-
ated comorbidities. 
According to Markwald et al.,28 sleep plays a key role 
in energy metabolism, and insufficient sleep can contrib-
ute to being overweight, cardiovascular diseases, and psy-
chological disorders such as exhaustion, anxiety, depression 
and a decrease in school and professional performances. 
Martins et al.,1 stated that weight gain occurs because there 
is a reduction in the amount of leptin, the satiety hormone, 
produced during sleep. As the individual does not have a 
good quality of sleep, there is a decrease in the amount of 
leptin produced during sleep and an increase in the ghre-
lin hormone which stimulates hunger; hence, the indi-
vidual does not feel satiated after a meal and therefore 
increases his or her calorie intake, which, as a consequence, 
results in an increase in body weight, which in turn favors 
OSAS, thereby leading to a vicious cycle.1,28
In OSAS, apnea and hypopnea lead to hypoxia and 
hypoxia-reoxygenation states, which, in turn, causes an 
inflammatory process and oxidative stress and, in com-
bination with obesity, favors the formation of atheroma 
plaques.29-31 In our study, we found that 53.8% of obese 
individuals have systemic arterial hypertension (SAH). 
According to Logan et al.,32 patients with OSAS have 
a decrease in baroreceptor sensitivity, changes in salt and 
water metabolism, which may contribute to an increase 
in systemic arterial hypertension, when they have apnea 
symptoms, there is a decrease in oxygen saturation and 
an increase in carbon dioxide levels, which stimulates the 
carotid chemoreceptors, thereby causing vasoconstriction 
and a consequent increase in peripheral vascular resistance 
and systemic blood pressure.31-33 
In analyzing the BQ scores, we found that the indi-
viduals with obesity participating in the multidisciplinary 
preoperative preparation program for bariatric surgery 
at Hospital de Clínicas – Unicamp were at a high risk 
(80.34%) of developing OSAS, versus 19.66% at low risk, 
thus confirming that obesity is a disease clearly identified 
as a risk factor for the development of OSAS. Pinto et 
al.,34 pointed out controversy as to which are the most 
significant predictive parameters of obesity leading to 
this association.
In our study, when correlating the risk of developing 
OSAS with the variables age, weight, height, BMI, NC, 
waist circumference, hip circumference and WHR of in-
dividuals participating in the study, we found that age 
and NC had a p-value=0.0001, whereas BMI, waist cir-
cumference and WHR had p-values=0.0111; 0.008; 0.0032, 
respectively, i.e., significant values contributing to a high 
risk of developing OSAS; nevertheless, weight, height and 
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hip circumference were not statistically significant for 
such development. 
Ever since 1990, investigators have reported that the 
variation in NC measurement compared with other an-
thropometric measurements is the best clinical predictor 
for the development and severity of OSAS.34-37 
Katz et al.38 found that BMI, age and NC are signifi-
cant predictors of OSAS. The incidence of OSAS peaks 
in the age group 50-60 years, but in individuals with a 
high BMI, this trend tends to peak in the age group 40-50. 
It is a fact, however, that OSAS can affect individuals in 
any age group.2,6,14,38
The presence of only one population sample profile, 
such as obesity, limits the study with respect to comparing 
anthropometric characteristics with the risk of developing 
OSAS. Nevertheless, we were able to detect that minimal 
variations in BMI, neck circumference, waist circumference, 
and waist-to-hip ratio may alter the risk of developing 
OSAS: the higher these values, the greater the risk of de-
veloping OSAS. Thus, further studies are needed to com-
pare the BQ responses for different BMI profiles.
conclusion
The BQ proved to be an effective and reliable tool for 
demonstrating the high-risk prevalence for developing 
OSAS in individuals suffering from obesity.
resuMo
Síndrome da apneia obstrutiva do sono em indivíduos 
portadores de obesidade: um estudo transversal
Introdução: A síndrome da apneia obstrutiva do sono 
(SAOS) é uma patologia respiratória, caracterizada por 
episódios recorrentes de apneia e hipopneia, resultando 
na cessação ou redução do fluxo aéreo. A obesidade é um 
dos principais fatores de risco para o desenvolvimento da 
SAOS. Foram criadas formas de auxiliar o diagnóstico da 
doença por meio de questionários de fácil aplicação e 
baixo custo, como o questionário de Berlim (QB). 
Objetivo: Avaliar a eficácia do QB para rastreamento do 
risco de desenvolvimento da SAOS em indivíduos porta-
dores de obesidade que participaram do grupo multidis-
ciplinar de preparo pré-operatório para cirurgia bariátri-
ca do Hospital de Clínicas da Universidade Estadual de 
Campinas (HC-Unicamp). 
Método: O estudo foi observacional, descritivo e trans-
versal, e avaliou portadores de obesidade que participavam 
do Programa multidisciplinar de preparo pré-operatório 
para cirurgia bariátrica do HC-Unicamp foram avaliados 
por meio do QB. 
Resultados: O QB foi capaz de detectar que mínimas 
oscilações no índice de massa corpórea (IMC), na circun-
ferência cervical (Ccv), na circunferência da cintura e na 
relação cintura/quadril (RCQ) podem alterar o risco de 
desenvolvimento de SAOS, sendo que quanto maior esses 
valores, maior o risco de desenvolvimento de SAOS. 
Conclusão: O QB é uma ferramenta eficaz e fidedigna 
em demonstrar a prevalência do risco alto para o desen-
volvimento da SAOS em indivíduos portadores de obesi-
dade, dado esse que, quando correlacionado com IMC, 
aumento de idade, medida de cintura, Ccv e RCQ, faz o 
risco tender a aumentar de forma exponencial. 
Palavras-chave: obesidade, apneia obstrutiva do sono, 
apneia, cirurgia bariátrica, inquéritos e questionários.
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